Stockscreener 앱 받기
68.06
0.19%
0.13
전일 마감가:
$67.93
열려 있는:
$68
하루 거래량:
1.89M
Relative Volume:
0.65
시가총액:
$15.14B
수익:
$4.03B
순이익/손실:
$556.70M
주가수익비율:
28.72
EPS:
2.37
순현금흐름:
$970.10M
1주 성능:
+1.34%
1개월 성능:
+4.87%
6개월 성능:
+5.39%
1년 성능:
-18.38%
1일 변동 폭
$67.67
$68.33
1주일 범위
$66.78
$69.07
52주 변동 폭
$51.90
$84.67
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
HOLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
68.06 | 14.88B | 4.03B | 556.70M | 970.10M | 2.37 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
홀로직 Stock (HOLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-27 | 재확인 | Needham | Hold |
| 2025-03-03 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | 다운그레이드 | Needham | Buy → Hold |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-12-10 | 재확인 | Needham | Buy |
| 2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-27 | 개시 | Stephens | Overweight |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-14 | 업그레이드 | Needham | Hold → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-05 | 재확인 | Needham | Buy |
| 2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 재확인 | Needham | Buy |
| 2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-01-31 | 재확인 | Needham | Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
Stock Analysis | Hologic OutlookMixed Signals Amid Sector Volatility - AInvest
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It? - The Globe and Mail
RadNet hires Hologic, Bausch + Lomb alum Jane Mazur - Medical Marketing and Media
Hologic's Diagnostics Arm Set For Long-Term Upside: What's Behind It? - Barchart.com
RBC Capital Upgrades Hologic to Outperform with $87 Price Target - AInvest
RBC Capital Upgrades Hologic (HOLX) to Outperform with Raised Pr - GuruFocus
Hologic’s Growth Story Looks Set For A Comeback - Finimize
Forecasting the Future: Next-Generation Biopsy-Based Cancer - openPR.com
Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings? - The Globe and Mail
Should You Buy, Sell Or Hold Hologic Stock Post Q3 Earnings? - Barchart.com
Hpv And Pap Testing Market Generated Opportunities, Future - openPR.com
RBC Capital Upgrades Hologic to Outperform From Sector Perform, Adjusts PT to $87 From $72 - MarketScreener
RBC Capital upgrades Hologic stock to Outperform on expected growth By Investing.com - Investing.com Canada
RBC Capital upgrades Hologic stock to Outperform on expected growth - Investing.com
Molecular Diagnostics Market Expands with Infectious Disease - openPR.com
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
Analysts Have Made A Financial Statement On Hologic, Inc.'s (NASDAQ:HOLX) Third-Quarter Report - simplywall.st
Why Hologic (HOLX) is a Top Value Stock for the Long-Term - Yahoo Finance
Interpreting Hologic (HOLX) International Revenue Trends - Yahoo Finance
What are analysts’ price targets for Hologic Inc. in the next 12 monthsMassive portfolio appreciation - Jammu Links News
Is Hologic Inc. a good long term investmentIdentify winners with top-tier analysis - Jammu Links News
Hologic, Inc. (NASDAQ:HOLX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates - 富途牛牛
Hologic's Q3 Earnings Beat and Strategic Innovations: A Convincing Case for Value Investors - AInvest
Hologic Analyst Estimates: Third-Quarter Report Recap - AInvest
Analyst Estimates: Here's What Brokers Think Of Hologic, Inc. (NASDAQ:HOLX) After Its Third-Quarter Report - Yahoo Finance
What makes Hologic Inc. stock price move sharplyFree Predictions - Jammu Links News
What are Hologic Inc. company’s key revenue driversAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is it the right time to buy Hologic Inc. stockCapitalize on emerging market opportunities - Jammu Links News
Is Hologic Inc. stock overvalued or undervaluedIdentify safe investments with exceptional yields - Jammu Links News
What institutional investors are buying Hologic Inc. stockSpectacular growth rates - Jammu Links News
How does Hologic Inc. compare to its industry peersMaximize returns with strategic trading plans - Jammu Links News
Published on: 2025-08-03 05:06:54 - Jammu Links News
Hologic targets mid-single-digit organic revenue growth in 2026 as Breast Health rebounds and tariff mitigation advances - MSN
What is the risk reward ratio of investing in Hologic Inc. stockGet timely alerts on top market movers - Jammu Links News
Hologic, Inc. (NASDAQ:HOLX) Q3 2025 Earnings Call Transcript - Insider Monkey
Hologic’s Earnings Call: Strong Q3 Performance and Optimism - The Globe and Mail
Hologic Reports Strong Q3 2025 Earnings, Exceeds Guidance - MSN
BioZorb Lawsuit and Settlement Information: August 2025 - AboutLawsuits.com
Hologic (HOLX) Gets a Buy from J.P. Morgan - The Globe and Mail
Hologic 2025 Q3 Earnings Beats Expectations as Net Income Grows 0.2% - AInvest
Hologic, Inc. shares fall 1.53% after-hours following Morgan Stanley's price target adjustment to $69. - AInvest
Real time scanner hits for Hologic Inc. explainedExit Ready Momentum Stock Watchlist Expanded - metal.it
Mizuho raises Hologic stock price target to $75 on strong quarterly results - Investing.com Canada
Hologic (HOLX) Sees Updated Analyst Ratings and Price Targets | - GuruFocus
How did Oolong Pharmaceutical's revenue and expenses trend in Q4 2024? - AInvest
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.58%
자본화:
|
볼륨(24시간):